To examine the mechanism by which lipids cause insulin resistance in humans, skeletal muscle glycogen and glucose-6-phosphate concentrations were measured every 15 min by simultaneous 13C and 31P nuclear magnetic resonance spectroscopy in nine healthy subjects in the presence of low (0.18±0.02 mM [mean±SEM]; control) or high (1.93±0.04 mM; lipid infusion) plasma free fatty acid levels under euglycemic (~ 5.2 mM) hyperinsulinemic (~ 400 pM) clamp conditions for 6 h. During the initial 3.5 h of the clamp the rate of whole-body glucose uptake was not affected by lipid infusion, but it then decreased continuously to be ~ 46% of control values after 6 h (P < 0.00001). Augmented lipid oxidation was accompanied by a ~ 40% reduction of oxidative glucose metabolism starting during the third hour of lipid infusion (P < 0.05). Rates of muscle glycogen synthesis were similar during the first 3 h of lipid and control infusion, but thereafter decreased to ~ 50% of control values (4.0±1.0 vs. 9.3±1.6 μmol/[kg · min], P < 0.05). Reduction of muscle glycogen synthesis by elevated plasma free fatty acids was preceded by a fall of muscle glucose-6-phosphate concentrations starting at ~ 1.5 h (195±25 vs. control: 237±26 μM; P < 0.01). Therefore in contrast to the originally postulated mechanism in which free fatty acids were thought to inhibit insulin-stimulated glucose uptake in muscle through initial inhibition of pyruvate dehydrogenase these results demonstrate that free fatty acids induce insulin resistance in humans by initial inhibition of glucose transport/phosphorylation which is then followed by an ~ 50% reduction in both the rate of muscle glycogen synthesis and glucose oxidation

Roden, M., Price, T., Perseghin, G., Petersen, K., Rothman, D., Cline, G., et al. (1996). Mechanism of free fatty acid-induced insulin resistance in humans. THE JOURNAL OF CLINICAL INVESTIGATION, 97(12), 2859-2865 [10.1172/JCI118742].

Mechanism of free fatty acid-induced insulin resistance in humans

PERSEGHIN, GIANLUCA;
1996

Abstract

To examine the mechanism by which lipids cause insulin resistance in humans, skeletal muscle glycogen and glucose-6-phosphate concentrations were measured every 15 min by simultaneous 13C and 31P nuclear magnetic resonance spectroscopy in nine healthy subjects in the presence of low (0.18±0.02 mM [mean±SEM]; control) or high (1.93±0.04 mM; lipid infusion) plasma free fatty acid levels under euglycemic (~ 5.2 mM) hyperinsulinemic (~ 400 pM) clamp conditions for 6 h. During the initial 3.5 h of the clamp the rate of whole-body glucose uptake was not affected by lipid infusion, but it then decreased continuously to be ~ 46% of control values after 6 h (P < 0.00001). Augmented lipid oxidation was accompanied by a ~ 40% reduction of oxidative glucose metabolism starting during the third hour of lipid infusion (P < 0.05). Rates of muscle glycogen synthesis were similar during the first 3 h of lipid and control infusion, but thereafter decreased to ~ 50% of control values (4.0±1.0 vs. 9.3±1.6 μmol/[kg · min], P < 0.05). Reduction of muscle glycogen synthesis by elevated plasma free fatty acids was preceded by a fall of muscle glucose-6-phosphate concentrations starting at ~ 1.5 h (195±25 vs. control: 237±26 μM; P < 0.01). Therefore in contrast to the originally postulated mechanism in which free fatty acids were thought to inhibit insulin-stimulated glucose uptake in muscle through initial inhibition of pyruvate dehydrogenase these results demonstrate that free fatty acids induce insulin resistance in humans by initial inhibition of glucose transport/phosphorylation which is then followed by an ~ 50% reduction in both the rate of muscle glycogen synthesis and glucose oxidation
Articolo in rivista - Articolo scientifico
free fatty acids; glucose transport; glucose-6-phosphate; muscle glycogen; nuclear magnetic resonance spectroscopy; Medicine (all)
English
1996
97
12
2859
2865
reserved
Roden, M., Price, T., Perseghin, G., Petersen, K., Rothman, D., Cline, G., et al. (1996). Mechanism of free fatty acid-induced insulin resistance in humans. THE JOURNAL OF CLINICAL INVESTIGATION, 97(12), 2859-2865 [10.1172/JCI118742].
File in questo prodotto:
File Dimensione Formato  
JCI-Roden-96-2.pdf

Solo gestori archivio

Dimensione 173.2 kB
Formato Adobe PDF
173.2 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/165548
Citazioni
  • Scopus 1298
  • ???jsp.display-item.citation.isi??? 1172
Social impact